ALT vs GS · rev $20.0K vs P/E 20, $324.25B cap
Altimmune Inc (ALT) versus Goldman Sachs Group Inc (GS) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
GS does not have a complete income-statement cache yet.
ALT currently screens at market cap $527.0M. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Not investment advice. Open the ALT and GS stock pages for the full models.
Not investment advice.